Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible
EQS-News: Immunic AG: Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
EQS-News: Immunic, Inc.: Immunic Highlights 2023 Accomplishments and Upcoming Milestones finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Immunic (IMUX) Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.